| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |